Table of Contents
ISRN Ophthalmology
Volume 2013 (2013), Article ID 261386, 14 pages
http://dx.doi.org/10.1155/2013/261386
Review Article

New Therapeutic Targets for Intraocular Pressure Lowering

1Department of Sense Organs, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal
2Department of Ophthalmology, São João Hospital, 4200-319 Porto, Portugal
3Department of Physiology and Cardiothoracic Surgery, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal

Received 13 May 2013; Accepted 30 May 2013

Academic Editors: T. Mimura and M. Sugimoto

Copyright © 2013 A. Rocha-Sousa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Sommer, J. M. Tielsch, J. Katz et al., “Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans: the Baltimore eye survey,” Archives of Ophthalmology, vol. 109, no. 8, pp. 1090–1095, 1991. View at Google Scholar · View at Scopus
  2. M. A. Kass, D. K. Heuer, E. J. Higginbotham et al., “The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma,” Archives of Ophthalmology, vol. 120, no. 6, pp. 701–713, 2002. View at Google Scholar · View at Scopus
  3. R. N. Weinreb, C. B. Toris, B. T. Gabelt, J. D. Lindsey, and P. L. Kaufman, “Effects of prostaglandins on the aqueous humor outflow pathways,” Survey of Ophthalmology, vol. 47, no. 4, supplement 1, pp. S53–S64, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. R. N. Weinreb and J. D. Lindsey, “Metalloproteinase gene transcription in human ciliary muscle cells with latanoprost,” Investigative Ophthalmology & Visual Science, vol. 43, no. 3, pp. 716–722, 2002. View at Google Scholar · View at Scopus
  5. C. B. Camras, A. H. Friedman, M. M. Rodrigues, B. J. Tripathi, R. C. Tripathi, and S. M. Podos, “Multiple dosing of prostaglandin F(2α) or epinephrine on cynomolgus monkey eyes—III. Histopathology,” Investigative Ophthalmology & Visual Science, vol. 29, no. 9, pp. 1428–1436, 1988. View at Google Scholar · View at Scopus
  6. P. L. Kaufman, “Pharmacologic trabeculocanalotomy: facilitating aqueous outflow by assaulting the meshwork cytoskeleton, junctional complexes, and extracellular matrix,” Archives of Ophthalmology, vol. 110, no. 1, pp. 34–36, 1992. View at Google Scholar · View at Scopus
  7. Y. Fukata, M. Amano, and K. Kaibuchi, “Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells,” Trends in Pharmacological Sciences, vol. 22, no. 1, pp. 32–39, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Honjo, H. Tanihara, M. Inatani et al., “Effects of Rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility,” Investigative Ophthalmology & Visual Science, vol. 42, no. 1, pp. 137–144, 2001. View at Google Scholar · View at Scopus
  9. B. Tian, B. Geiger, D. L. Epstein, and P. L. Kaufman, “Cytoskeletal involvement in the regulation of aqueous humor outflow,” Investigative Ophthalmology & Visual Science, vol. 41, no. 3, pp. 619–623, 2000. View at Google Scholar · View at Scopus
  10. B. Tian, L. C. Brumback, and P. L. Kaufman, “ML-7, chelerythrine and phorbol ester increase outflow facility in the monkey eye,” Experimental Eye Research, vol. 71, no. 6, pp. 551–566, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. P. V. Rao, P. Deng, Y. Sasaki, and D. L. Epstein, “Regulation of myosin light chain phosphorylation in the trabecular meshwork: role in aqueous humour outflow facility,” Experimental Eye Research, vol. 80, no. 2, pp. 197–206, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Thieme, M. Nuskovski, J. U. Nass, U. Pleyer, O. Strauss, and M. Wiederholt, “Mediation of calcium-independent contraction in trabecular meshwork through protein kinase C and rho-A,” Investigative Ophthalmology & Visual Science, vol. 41, no. 13, pp. 4240–4246, 2000. View at Google Scholar · View at Scopus
  13. F. J. Munoz-Negrete, M. Pérez-López, H. R. Won Kim, and G. Rebolleda, “New developments in glaucoma medical treatment,” Archivos de la Sociedad Española de Oftalmología, vol. 84, no. 10, pp. 491–500, 2009. View at Google Scholar
  14. M. Y. Avila, R. A. Stone, and M. M. Civan, “A1-, A2a- and A3-subtype adenosine receptors modulate intraocular pressure in the mouse,” British Journal of Pharmacology, vol. 134, no. 2, pp. 241–245, 2001. View at Google Scholar · View at Scopus
  15. G. Beidoe and S. A. Mousa, “Current primary open-angle glaucoma treatments and future directions,” Clinical Ophthalmology, vol. 6, pp. 1699–1707, 2012. View at Google Scholar
  16. A. J. Lee and I. Goldberg, “Emerging drugs for ocular hypertension,” Expert Opinion on Emerging Drugs, vol. 16, no. 1, pp. 137–161, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. M. D. Pinazo-Duran, V. Zanon-Moreno, J. J. Garcia-Medina, and R. Gallego-Pinazo, “Evaluation of presumptive biomarkers of oxidative stress, immune response and apoptosis in primary open-angle glaucoma,” Current Opinion in Pharmacology, vol. 13, no. 1, pp. 98–107, 2013. View at Google Scholar
  18. J. Wierzbowska, J. Robaszkiewicz, M. Figurska, and A. Stankiewicz, “Future possibilities in glaucoma therapy,” Case Reports and Clinical Practice Review, vol. 16, no. 11, pp. RA252–RA259, 2010. View at Google Scholar · View at Scopus
  19. M. F. Armaly, D. E. Krueger, and L. Maunder, “Biostatistical analysis of the collaborative glaucoma study—I. Summary report of the risk factors for glaucomatous visual-field defects,” Archives of Ophthalmology, vol. 98, no. 12, pp. 2163–2171, 1980. View at Google Scholar · View at Scopus
  20. Y. Shiose, Y. Kitazawa, S. Tsukahara et al., “Epidemiology of glaucoma in Japan. A nationwide glaucoma survey,” Japanese Journal of Ophthalmology, vol. 35, no. 2, pp. 133–155, 1991. View at Google Scholar · View at Scopus
  21. M. Amano, M. Nakayama, and K. Kaibuchi, “Rho-kinase/ROCK: a key regulator of the cytoskeleton and cell polarity,” Cytoskeleton, vol. 67, no. 9, pp. 545–554, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Hahmann and T. Schroeter, “Rho-kinase inhibitors as therapeutics: from pan inhibition to isoform selectivity,” Cellular and Molecular Life Sciences, vol. 67, no. 2, pp. 171–177, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Colligris, A. Crooke, F. Huete, and J. Pintor, “Potential role of Rho-associated protein kinase inhibitors for glaucoma treatment,” Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, vol. 6, no. 2, pp. 89–98, 2012. View at Google Scholar
  24. E. Nakajima, T. Nakajima, Y. Minagawa, T. R. Shearer, and M. Azuma, “Contribution of ROCK in contraction of trabecular meshwork: proposed mechanism for regulating aqueous outflow in monkey and human eyes,” Journal of Pharmaceutical Sciences, vol. 94, no. 4, pp. 701–708, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Tokushige, M. Inatani, S. Nemoto et al., “Effects of topical administration of Y-39983, a selective Rho-associated protein kinase inhibitor, on ocular tissues in rabbits and monkeys,” Investigative Ophthalmology & Visual Science, vol. 48, no. 7, pp. 3216–3222, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Zhang, R. Maddala, and P. V. Rao, “Novel molecular insights into RhoA GTPase-induced resistance to aqueous humor outflow through the trabecular meshwork,” American Journal of Physiology, vol. 295, no. 5, pp. C1057–C1070, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. X. Fang, Y. T. Chen, E. H. Sessions et al., “Synthesis and biological evaluation of 4-quinazolinones as Rho kinase inhibitors,” Bioorganic & Medicinal Chemistry Letters, vol. 21, no. 6, pp. 1844–1848, 2011. View at Publisher · View at Google Scholar
  28. D. R. Anderson, S. M. Drance, and M. Schulzer, “Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures,” American Journal of Ophthalmology, vol. 126, no. 4, pp. 487–497, 1998. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Zhang, L. Zhang, and R. N. Weinreb, “Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma,” Nature Reviews Drug Discovery, vol. 11, no. 7, pp. 541–559, 2012. View at Google Scholar
  30. V. P. Rao and D. L. Epstein, “Rho GTPase/Rho kinase inhibition as a novel target for the treatment of glaucoma,” BioDrugs, vol. 21, no. 3, pp. 167–177, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Lepple-Wienhues, F. Stahl, U. Willner, R. Schafer, and M. Wiederholt, “Endothelin-evoked contractions in bovine ciliary muscle and trabecular meshwork: interaction with calcium, nifedipine and nickel,” Current Eye Research, vol. 10, no. 10, pp. 983–989, 1991. View at Google Scholar · View at Scopus
  32. G. Renieri, L. Choritz, R. Rosenthal, S. Meissner, N. Pfeiffer, and H. Thieme, “Effects of endothelin-1 on calcium-independent contraction of bovine trabecular meshwork,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 246, no. 8, pp. 1107–1115, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Choritz, M. Machert, and H. Thieme, “Correlation of endothelin-1 concentration in aqueous humor with intraocular pressure in primary open angle and pseudoexfoliation glaucoma,” Investigative Ophthalmology & Visual Science, vol. 53, no. 11, pp. 7336–7342, 2012. View at Google Scholar
  34. M. Cellini, P. Versura, E. Zamparini, E. Bendo, and E. C. Campos, “Effects of endothelin-1 and flunarizine on human trabecular meshwork cell contraction,” Experimental Biology and Medicine, vol. 231, no. 6, pp. 1081–1084, 2006. View at Google Scholar · View at Scopus
  35. L. Choritz, R. Rosenthal, M. Fromm, M. H. Foerster, and H. Thieme, “Pharmacological and functional characterization of endothelin receptors in bovine trabecular meshwork and ciliary muscle,” Ophthalmic Research, vol. 37, no. 4, pp. 179–187, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Wiederholt, A. Sturm, and A. Lepple-Wienhues, “Relaxation of trabecular meshwork and ciliary muscle by release of nitric oxide,” Investigative Ophthalmology & Visual Science, vol. 35, no. 5, pp. 2515–2520, 1994. View at Google Scholar · View at Scopus
  37. M. De Caestecker, “The transforming growth factor-β superfamily of receptors,” Cytokine and Growth Factor Reviews, vol. 15, no. 1, pp. 1–11, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. M. A. Prendes, “The role of transforming growth factor beta in glaucoma and the therapeutic implications,” British Journal of Ophthalmology, vol. 97, no. 6, pp. 680–686, 2013. View at Publisher · View at Google Scholar
  39. J. Gottanka, D. Chan, M. Eichhorn, E. Lütjen-Drecoll, and C. R. Ethier, “Effects of TGF-beta2 in perfused human eyes,” Investigative Ophthalmology & Visual Science, vol. 45, no. 1, pp. 153–158, 2004. View at Google Scholar
  40. S. H. Min, T.-I. Lee, Y. S. Chung, and H. K. Kim, “Transforming growth factor-beta levels in human aqueous humor of glaucomatous, diabetic and uveitic eyes,” Korean Journal of Ophthalmology, vol. 20, no. 3, pp. 162–165, 2006. View at Google Scholar · View at Scopus
  41. R. C. Tripathi, J. Li, F. A. Chan, and B. J. Tripathi, “Aqueous humor in glaucomatous eyes contains an increased level of TGF-β2,” Experimental Eye Research, vol. 59, no. 6, pp. 723–728, 1994. View at Publisher · View at Google Scholar · View at Scopus
  42. A. R. Shepard, J. Cameron Millar, I.-H. Pang, N. Jacobson, W.-H. Wang, and A. F. Clark, “Adenoviral gene transfer of active human transforming growth factor-β2 elevates intraocular pressure and reduces outflow facility in rodent eyes,” Investigative Ophthalmology & Visual Science, vol. 51, no. 4, pp. 2067–2076, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. R. H. Trivedi, M. Nutaitis, D. Vroman, and C. E. Crosson, “Influence of race and age on aqueous humor levels of transforming growth factor-beta 2 in glaucomatous and nonglaucomatous eyes,” Journal of Ocular Pharmacology and Therapeutics, vol. 27, no. 5, pp. 477–480, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. B. Da, Y. Cao, H. Wei, Z. Chen, Y. Shui, and Z. Li, “Antagonistic effects of tranilast on proliferation and collagen synthesis induced by TGF-β2 in cultured human trabecular meshwork cells,” Journal of Huazhong University of Science and Technology, vol. 24, no. 5, pp. 490–496, 2004. View at Google Scholar · View at Scopus
  45. R. J. Wordinger, D. L. Fleenor, P. E. Hellberg et al., “Effects of TGF-β2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma,” Investigative Ophthalmology & Visual Science, vol. 48, no. 3, pp. 1191–1200, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. R. Fuchshofer, U. Welge-Lussen, and E. Lütjen-Drecoll, “The effect of TGF-β2 on human trabecular meshwork extracellular proteolytic system,” Experimental Eye Research, vol. 77, no. 6, pp. 757–765, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. P. B. Liton, X. Liu, P. Challa, D. L. Epstein, and P. Gonzalez, “Induction of TGF-β1 in the trabecular meshwork under cyclic mechanical stress,” Journal of Cellular Physiology, vol. 205, no. 3, pp. 364–371, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. R. Fuchshofer and E. R. Tamm, “The role of TGF-β in the pathogenesis of primary open-angle glaucoma,” Cell and Tissue Research, vol. 347, no. 1, pp. 279–290, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. U. Schlötzer-Schrehardt, M. Zenkel, M. Küchle, L. Y. Sakai, and G. O. H. Naumann, “Role of transforming growth factor-β1 and its latent form binding protein in pseudoexfoliation syndrome,” Experimental Eye Research, vol. 73, no. 6, pp. 765–780, 2001. View at Publisher · View at Google Scholar · View at Scopus
  50. Y. Nakamura, S. Hirano, K. Suzuki, K. Seki, T. Sagara, and T. Nishida, “Signaling mechanism of TGF-β1-induced collagen contraction mediated by bovine trabecular meshwork cells,” Investigative Ophthalmology & Visual Science, vol. 43, no. 11, pp. 3465–3472, 2002. View at Google Scholar · View at Scopus
  51. U. Welge-Lüßen, C. A. May, and E. Lütjen-Drecoll, “Induction of tissue transglutaminase in the trabecular meshwork by TGF- β1 and TGF-β2,” Investigative Ophthalmology & Visual Science, vol. 41, no. 8, pp. 2229–2238, 2000. View at Google Scholar · View at Scopus
  52. E. R. Tamm, P. Russell, D. L. Epstein, D. H. Johnson, and J. Piatigorsky, “Modulation of myocilin/TIGR expression in human trabecular meshwork,” Investigative Ophthalmology & Visual Science, vol. 40, no. 11, pp. 2577–2582, 1999. View at Google Scholar · View at Scopus
  53. D. D. Konz, C. Flügel-Koch, A. Ohlmann, and E. R. Tamm, “Myocilin in the trabecular meshwork of eyes with primary open-angle glaucoma,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 247, no. 12, pp. 1643–1649, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. B. S. Weston, N. A. Wahab, and R. M. Mason, “CTGF mediates TGF-β-induced fibronectin matrix deposition by upregulating active α5β1 integrin in human mesangial cells,” Journal of the American Society of Nephrology, vol. 14, no. 3, pp. 601–610, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. D. Kothapalli and G. R. Grotendorst, “CTGF modulates cell cycle progression in cAMP-arrested NRK fibroblasts,” Journal of Cellular Physiology, vol. 182, no. 1, pp. 119–126, 2000. View at Google Scholar · View at Scopus
  56. M. Inatani, H. Tanihara, H. Katsuta, M. Honjo, N. Kido, and Y. Honda, “Transforming growth factor-β2 levels in aqueous humor of glaucomatous eyes,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 239, no. 2, pp. 109–113, 2001. View at Google Scholar · View at Scopus
  57. U. B. Kottler, A. G. M. Jünemann, T. Aigner, M. Zenkel, C. Rummelt, and U. Schlötzer-Schrehardt, “Comparative effects of TGF-β1 and TGF-β2 on extracellular matrix production, proliferation, migration, and collagen contraction of human Tenon's capsule fibroblasts in pseudoexfoliation and primary open-angle glaucoma,” Experimental Eye Research, vol. 80, no. 1, pp. 121–134, 2005. View at Publisher · View at Google Scholar · View at Scopus
  58. J. Gottanka, C. Flügel-Koch, P. Martus, D. H. Johnson, and E. Lütjen-Drecoll, “Correlation of pseudoexfoliative material and optic nerve damage in pseudoexfoliation syndrome,” Investigative Ophthalmology & Visual Science, vol. 38, no. 12, pp. 2435–2446, 1997. View at Google Scholar · View at Scopus
  59. J. K. G. Crean, D. Finlay, M. Murphy et al., “The role of p42/44 MAPK and protein kinase B in connective tissue growth factor induced extracellular matrix protein production, cell migration, and actin cytoskeletal rearrangement in human mesangial cells,” Journal of Biological Chemistry, vol. 277, no. 46, pp. 44187–44194, 2002. View at Publisher · View at Google Scholar · View at Scopus
  60. J. K. Crean, F. Furlong, D. Finlay et al., “Connective tissue growth factor [CTGF]/CCN2 stimulates mesangial cell migration through integrated dissolution of focal adhesion complexes and activation of cell polarization,” The FASEB Journal, vol. 18, no. 13, pp. 1541–1543, 2004. View at Publisher · View at Google Scholar · View at Scopus
  61. J. K. Crean, F. Furlong, D. Mitchell, E. McArdle, C. Godson, and F. Martin, “Connective tissue growth factor/CCN2 stimulates actin disassembly through Akt/protein kinase B-mediated phosphorylation and cytoplasmic translocation of p27(Kip-1),” The FASEB Journal, vol. 20, no. 10, pp. 1712–1714, 2006. View at Publisher · View at Google Scholar · View at Scopus
  62. F. Furlong, J. Crean, L. Thornton, R. O'Leary, M. Murphy, and F. Martin, “Dysregulated intracellular signaling impairs CTGF-stimulated responses in human mesangial cells exposed to high extracellular glucose,” American Journal of Physiology, vol. 292, no. 6, pp. F1691–F1700, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. J. G. Browne, S. L. Ho, R. Kane et al., “Connective tissue growth factor is increased in pseudoexfoliation glaucoma,” Investigative Ophthalmology & Visual Science, vol. 52, no. 6, pp. 3660–3666, 2011. View at Google Scholar
  64. W. M. Grant, “Experimental aqueous perfusion in enucleated human eyes,” Archives of Ophthalmology, vol. 69, pp. 783–801, 1963. View at Google Scholar · View at Scopus
  65. M. Johnson, “What controls aqueous humour outflow resistance?” Experimental Eye Research, vol. 82, no. 4, pp. 545–557, 2006. View at Publisher · View at Google Scholar · View at Scopus
  66. E. Lutjen-Drecoll, T. Shimizu, M. Rohrbach, and J. W. Rohen, “Quantitative analysis of “plaque material” between ciliary muscle tips in normal- and glaucomatous eyes,” Experimental Eye Research, vol. 42, no. 5, pp. 457–465, 1986. View at Google Scholar · View at Scopus
  67. J. W. Rohen, E. Lutjen-Drecoll, C. Flugel, M. Meyer, and I. Grierson, “Ultrastructure of the trabecular meshwork in untreated cases of primary open-angle glaucoma (POAG),” Experimental Eye Research, vol. 56, no. 6, pp. 683–692, 1993. View at Publisher · View at Google Scholar · View at Scopus
  68. A. Leask and D. J. Abraham, “All in the CCN family: essential matricellular signaling modulators emerge from the bunker,” Journal of Cell Science, vol. 119, no. 23, pp. 4803–4810, 2006. View at Publisher · View at Google Scholar · View at Scopus
  69. H. Yokoi, M. Mukoyama, A. Sugawara et al., “Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis,” American Journal of Physiology, vol. 282, no. 5, pp. F933–F942, 2002. View at Google Scholar · View at Scopus
  70. U. Schlötzer-Schrehardt, K. Von der Mark, L. Y. Sakai, and G. O. H. Naumann, “Increased extracellular deposition of fibrillin-containing fibrils in pseudoexfoliation syndrome,” Investigative Ophthalmology & Visual Science, vol. 38, no. 5, pp. 970–984, 1997. View at Google Scholar · View at Scopus
  71. R. Fuchshofer, M. Birke, U. Welge-Lussen, D. Kook, and E. Lütjen-Drecoll, “Transforming growth factor-β2 modulated extracellular matrix component expression in cultured human optic nerve head astrocytes,” Investigative Ophthalmology & Visual Science, vol. 46, no. 2, pp. 568–578, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. R. Fuchshofer, A. H. L. Yu, U. Welge-Lüssen, and E. R. Tamm, “Bone morphogenetic protein-7 is an antagonist of transforming growth factor-β2 in human trabecular meshwork cells,” Investigative Ophthalmology & Visual Science, vol. 48, no. 2, pp. 715–726, 2007. View at Publisher · View at Google Scholar · View at Scopus
  73. B. Junglas, S. Kuespert, A. A. Seleem et al., “Connective tissue growth factor causes glaucoma by modifying the actin cytoskeleton of the trabecular meshwork,” American Journal of Pathology, vol. 180, no. 6, pp. 2386–2403, 2012. View at Google Scholar
  74. P. Iyer, R. Maddala, P. P. Pattabiraman, and P. V. Rao, “Connective tissue growth factor-mediated upregulation of neuromedin U expression in trabecular meshwork cells and its role in homeostasis of aqueous humor outflow,” Investigative Ophthalmology & Visual Science, vol. 53, no. 8, pp. 4952–4962, 2012. View at Google Scholar
  75. A. Lepple-Wienhues, R. Rauch, A. F. Clark, A. Grassmann, S. Berweck, and M. Wiederholt, “Electrophysiological properties of cultured human trabecular meshwork cells,” Experimental Eye Research, vol. 59, no. 3, pp. 305–311, 1994. View at Publisher · View at Google Scholar · View at Scopus
  76. F. Stumpff, O. Strauss, M. Boxberger, and M. Wiederholt, “Characterization of maxi-K-channels in bovine trabecular meshwork and their activation by cyclic guanosine monophosphate,” Investigative Ophthalmology & Visual Science, vol. 38, no. 9, pp. 1883–1892, 1997. View at Google Scholar · View at Scopus
  77. J. A. Nathanson and M. McKee, “Identification of an extensive system of nitric oxide-producing cells in the ciliary muscle and outflow pathway of the human eye,” Investigative Ophthalmology & Visual Science, vol. 36, no. 9, pp. 1765–1773, 1995. View at Google Scholar · View at Scopus
  78. S. Moncada, R. M. J. Palmer, and E. A. Higgs, “Nitric oxide: physiology, pathophysiology, and pharmacology,” Pharmacological Reviews, vol. 43, no. 2, pp. 109–142, 1991. View at Google Scholar · View at Scopus
  79. M. T. Nelson and J. M. Quayle, “Physiological roles and properties of potassium channels in arterial smooth muscle,” American Journal of Physiology, vol. 268, no. 4, pp. C799–C822, 1995. View at Google Scholar · View at Scopus
  80. P. P. Pattabiraman and P. V. Rao, “Mechanistic basis of Rho GTPase-induced extracellular matrix synthesis in trabecular meshwork cells,” American Journal of Physiology, vol. 298, no. 3, pp. C749–C763, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. F. Stumpff and M. Wiederholt, “Regulation of trabecular meshwork contractility,” Ophthalmologica, vol. 214, no. 1, pp. 33–53, 2000. View at Publisher · View at Google Scholar · View at Scopus
  82. Y. Oike and M. Tabata, “Angiopoietin-like proteins—potential therapeutic targets for metabolic syndrome and cardiovascular disease,” Circulation Journal, vol. 73, no. 12, pp. 2192–2197, 2009. View at Publisher · View at Google Scholar · View at Scopus
  83. I. Kim, H.-G. Kim, H. Kim et al., “Hepatic expression, synthesis and secretion of a novel fibrinogen/angiopoietin-related protein that prevents endothelial-cell apoptosis,” Biochemical Journal, vol. 346, no. 3, pp. 603–610, 2000. View at Publisher · View at Google Scholar · View at Scopus
  84. G. Camenisch, M. T. Pisabarro, D. Sherman et al., “ANGPTL3 stimulates endothelial cell adhesion and migration via integrin αvβ3 and induces blood vessel formation in vivo,” Journal of Biological Chemistry, vol. 277, no. 19, pp. 17281–17290, 2002. View at Publisher · View at Google Scholar · View at Scopus
  85. Y. Katoh and M. Katoh, “Comparative integromics on Angiopoietin family members,” International Journal of Molecular Medicine, vol. 17, no. 6, pp. 1145–1149, 2006. View at Google Scholar · View at Scopus
  86. Y. Oike, Y. Ito, H. Maekawa et al., “Angiopoietin-related growth factor (AGF) promotes angiogenesis,” Blood, vol. 103, no. 10, pp. 3760–3765, 2004. View at Publisher · View at Google Scholar · View at Scopus
  87. T. Hato, M. Tabata, and Y. Oike, “The role of angiopoietin-like proteins in angiogenesis and metabolism,” Trends in Cardiovascular Medicine, vol. 18, no. 1, pp. 6–14, 2008. View at Publisher · View at Google Scholar · View at Scopus
  88. M. Ono, T. Shimizugawa, M. Shimamura et al., “Protein region important for regulation of lipid metabolism in angiopoietin-like 3 (ANGPTL3): ANGPTL3 is cleaved and activated in vivo,” Journal of Biological Chemistry, vol. 278, no. 43, pp. 41804–41809, 2003. View at Publisher · View at Google Scholar · View at Scopus
  89. Y. Oike, M. Akao, K. Yasunaga et al., “Angiopoietin-related growth factor antagonizes obesity and insulin resistance,” Nature Medicine, vol. 11, no. 4, pp. 400–408, 2005. View at Publisher · View at Google Scholar · View at Scopus
  90. A. Xu, M. C. Lam, K. W. Chan et al., “Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 17, pp. 6086–6091, 2005. View at Publisher · View at Google Scholar · View at Scopus
  91. R. Peek, B. Van Elske Gelderen, M. Bruinenberg, and A. Kijlstm, “Molecular cloning of a new angiopoietinlike factor from the human cornea,” Investigative Ophthalmology & Visual Science, vol. 39, no. 10, pp. 1782–1788, 1998. View at Google Scholar · View at Scopus
  92. P. Gonzalez, D. L. Epstein, and T. Borras, “Characterization of gene expression in human trabecular meshwork using single-pass sequencing of 1060 clones,” Investigative Ophthalmology & Visual Science, vol. 41, no. 12, pp. 3678–3693, 2000. View at Google Scholar · View at Scopus
  93. S. I. Tomarev, G. Wistow, V. Raymond, S. Dubois, and I. Malyukova, “Gene expression profile of the human trabecular meshwork: NEIBank sequence tag analysis,” Investigative Ophthalmology & Visual Science, vol. 44, no. 6, pp. 2588–2596, 2003. View at Publisher · View at Google Scholar · View at Scopus
  94. F. W. Rozsa, D. M. Reed, K. M. Scott et al., “Gene expression profile of human trabecular meshwork cells in response to long-term dexamethasone exposure,” Molecular Vision, vol. 12, pp. 125–141, 2006. View at Google Scholar · View at Scopus
  95. X. Zhao, K. E. Ramsey, D. A. Stephan, and P. Russell, “Gene and protein expression changes in human trabecular meshwork cells treated with transforming growth factor-β,” Investigative Ophthalmology & Visual Science, vol. 45, no. 11, pp. 4023–4034, 2004. View at Publisher · View at Google Scholar · View at Scopus
  96. K. M. Cadigan, “Wnt-β-catenin signaling,” Current Biology, vol. 18, no. 20, pp. R943–R947, 2008. View at Publisher · View at Google Scholar · View at Scopus
  97. W.-H. Wang, L. G. McNatt, I.-H. Pang et al., “Increased expression of the WNT antagonist sFRP-1 in glaucoma elevates intraocular pressure,” Journal of Clinical Investigation, vol. 118, no. 3, pp. 1056–1064, 2008. View at Publisher · View at Google Scholar · View at Scopus
  98. N. Comes and T. Borrás, “Individual molecular response to elevated intraocular pressure in perfused postmortem human eyes,” Physiological Genomics, vol. 38, no. 2, pp. 205–225, 2009. View at Publisher · View at Google Scholar · View at Scopus
  99. R. Peek, R. A. Kammerer, S. Frank, I. Otte-Höller, and J. R. Westphal, “The angiopoietin-like factor cornea-derived transcript 6 is a putative morphogen for human cornea,” Journal of Biological Chemistry, vol. 277, no. 1, pp. 686–693, 2002. View at Publisher · View at Google Scholar · View at Scopus
  100. B. T. Gabelt and P. L. Kaufman, “Changes in aqueous humor dynamics with age and glaucoma,” Progress in Retinal and Eye Research, vol. 24, no. 5, pp. 612–637, 2005. View at Publisher · View at Google Scholar · View at Scopus
  101. J. Kuchtey, M. E. Källberg, K. N. Gelatt, T. Rinkoski, A. M. Komàromy, and R. W. Kuchtey, “Angiopoietin-like 7 secretion is induced by glaucoma stimuli and its concentration is elevated in glaucomatous aqueous humor,” Investigative Ophthalmology & Visual Science, vol. 49, no. 8, pp. 3438–3448, 2008. View at Publisher · View at Google Scholar · View at Scopus
  102. F. Mabuchi, J. D. Lindsey, M. Aihara, M. R. Mackey, and R. N. Weinreb, “Optic nerve damage in mice with a targeted type I collagen mutation,” Investigative Ophthalmology & Visual Science, vol. 45, no. 6, pp. 1841–1845, 2004. View at Google Scholar
  103. M. Aihara, J. D. Lindsey, and R. N. Weinreb, “Ocular hypertension in mice with a targeted type I collagen mutation,” Investigative Ophthalmology & Visual Science, vol. 44, no. 4, pp. 1581–1585, 2003. View at Publisher · View at Google Scholar · View at Scopus
  104. N. Comes, L. K. Buie, and T. Borrás, “Evidence for a role of angiopoietin-like 7 (ANGPTL7) in extracellular matrix formation of the human trabecular meshwork: implications for glaucoma,” Genes to Cells, vol. 16, no. 2, pp. 243–259, 2011. View at Publisher · View at Google Scholar · View at Scopus
  105. J. A. Faralli, M. K. Schwinn, J. M. Gonzalez Jr., M. S. Filla, and D. M. Peters, “Functional properties of fibronectin in the trabecular meshwork,” Experimental Eye Research, vol. 88, no. 4, pp. 689–693, 2009. View at Publisher · View at Google Scholar · View at Scopus
  106. J. M. Bradley, J. Vranka, C. M. Colvis et al., “Effect of matrix metalloproteinases activity on outflow in perfused human organ culture,” Investigative Ophthalmology & Visual Science, vol. 39, no. 13, pp. 2649–2658, 1998. View at Google Scholar
  107. J. Chen, S. A. Runyan, and M. R. Robinson, “Novel ocular antihypertensive compounds in clinical trials,” Clinical Ophthalmology, vol. 5, no. 1, pp. 667–677, 2011. View at Publisher · View at Google Scholar · View at Scopus
  108. B. Tian, B. T. Gabelt, C. E. Crosson, and P. L. Kaufman, “Effects of adenosine agonists on intraocular pressure and aqueous humor dynamics in cynomolgus monkeys,” Experimental Eye Research, vol. 64, no. 6, pp. 979–989, 1997. View at Publisher · View at Google Scholar · View at Scopus
  109. C. E. Crosson, “Adenosine receptor activation modulates intraocular pressure in rabbits,” Journal of Pharmacology and Experimental Therapeutics, vol. 273, no. 1, pp. 320–326, 1995. View at Google Scholar · View at Scopus
  110. I. Avni, H. J. Garzozi, I. S. Barequet et al., “Treatment of dry eye syndrome with orally administered CF101: data from a phase 2 clinical trial,” Ophthalmology, vol. 117, no. 7, pp. 1287–1293, 2010. View at Publisher · View at Google Scholar · View at Scopus
  111. M. M. Civan and A. D. C. Macknight, “The ins and outs of aqueous humour secretion,” Experimental Eye Research, vol. 78, no. 3, pp. 625–631, 2004. View at Publisher · View at Google Scholar · View at Scopus
  112. J. A. Peterson, B. Tian, J. W. McLaren, W. C. Hubbard, B. Geiger, and P. L. Kaufman, “Latrunculins' effects on intraocular pressure, aqueous humor flow, and corneal endothelium,” Investigative Ophthalmology & Visual Science, vol. 41, no. 7, pp. 1749–1758, 2000. View at Google Scholar · View at Scopus
  113. R. Ritch, M. Schiewe, R. C. Zink et al., “Latrunculin B (INS115644) reduces intraocular pressure (IOP) in ocular hypertension (OHT) and primary open angle glaucoma (POAG),” Investigative Ophthalmology & Visual Science, vol. 51, 2010, ARVO E-Abstract and Poster 6432. View at Google Scholar
  114. S. K. Bhattacharya, E. J. Rockwood, S. D. Smith et al., “Proteomics reveal cochlin deposits associated with glaucomatous trabecular meshwork,” Journal of Biological Chemistry, vol. 280, no. 7, pp. 6080–6084, 2005. View at Publisher · View at Google Scholar · View at Scopus
  115. C. Kung, “A possible unifying principle for mechanosensation,” Nature, vol. 436, no. 7051, pp. 647–654, 2005. View at Publisher · View at Google Scholar · View at Scopus
  116. A. J. Patel, M. Lazdunski, and E. Honoré, “Lipid and mechano-gated 2P domain K+ channels,” Current Opinion in Cell Biology, vol. 13, no. 4, pp. 422–427, 2001. View at Publisher · View at Google Scholar · View at Scopus
  117. M. Goel, A. E. Sienkiewicz, R. Picciani, J. Wang, R. K. Lee, and S. K. Bhattacharya, “Cochlin, intraocular pressure regulation and mechanosensing,” PLoS ONE, vol. 7, no. 4, Article ID e34309, 2012. View at Publisher · View at Google Scholar · View at Scopus
  118. S. K. Bhattacharya, S. P. Annangudi, R. G. Salomon, R. W. Kuchtey, N. S. Peachey, and J. W. Crabb, “Cochlin deposits in the trabecular meshwork of the glaucomatous DBA/2J mouse,” Experimental Eye Research, vol. 80, no. 5, pp. 741–744, 2005. View at Publisher · View at Google Scholar · View at Scopus
  119. M. Goel, A. E. Sienkiewicz, R. Picciani, R. K. Lee, and S. K. Bhattacharya, “Cochlin induced TREK-1 co-expression and annexin A2 secretion: role in trabecular meshwork cell elongation and motility,” PLoS ONE, vol. 6, no. 8, Article ID e23070, 2011. View at Publisher · View at Google Scholar · View at Scopus
  120. A. J. Straiker, G. Maguire, K. Mackie, and J. Lindsey, “Localization of cannabinoid CB1 receptors in the human anterior eye and retina,” Investigative Ophthalmology & Visual Science, vol. 40, no. 10, pp. 2442–2448, 1999. View at Google Scholar · View at Scopus
  121. S. Yazulla, K. M. Studholme, H. H. McIntosh, and D. G. Deutsch, “Immunocytochemical localization of cannabinoid CB1 receptor and fatty acid amide hydrolase in rat retina,” Journal of Comparative Neurology, vol. 415, no. 1, pp. 80–90, 1999. View at Google Scholar
  122. S. Pinar-Sueiro, R. Rodríguez-Puertas, and E. Vecino, “Cannabinoid applications in glaucoma,” Archivos de la Sociedad Espanola de Oftalmologia, vol. 86, no. 1, pp. 16–23, 2011. View at Publisher · View at Google Scholar · View at Scopus
  123. F. Y. Chien, R.-F. Wang, T. W. Mittag, and S. M. Podos, “Effect of WIN 55212-2, a cannabinoid receptor agonist, on aqueous humor dynamics in monkeys,” Archives of Ophthalmology, vol. 121, no. 1, pp. 87–90, 2003. View at Google Scholar · View at Scopus
  124. A. Porcella, C. Maxia, G. L. Gessa, and L. Pani, “The synthetic cannabinoid WIN55212-2 decreases the intraocular pressure in human glaucoma resistant to conventional therapies,” European Journal of Neuroscience, vol. 13, no. 2, pp. 409–412, 2001. View at Publisher · View at Google Scholar · View at Scopus
  125. Y. F. Njie, A. Kumar, Z. Qiao, L. Zhong, and Z.-H. Song, “Noladin ether acts on trabecular meshwork cannabinoid (CB1) receptors to enhance aqueous humor outflow facility,” Investigative Ophthalmology & Visual Science, vol. 47, no. 5, pp. 1999–2005, 2006. View at Publisher · View at Google Scholar · View at Scopus
  126. B. D. Hudson, M. Beazley, A.-M. Szczesniak, A. Straiker, and M. E. M. Kelly, “Indirect sympatholytic actions at β-adrenoceptors account for the ocular hypotensive actions of cannabinoid receptor agonists,” Journal of Pharmacology and Experimental Therapeutics, vol. 339, no. 3, pp. 757–767, 2011. View at Publisher · View at Google Scholar · View at Scopus
  127. S. Rösch, R. Ramer, K. Brune, and B. Hinz, “R+-methanandamide and other cannabinoids induce the expression of cyclooxygenase-2 and matrix metalloproteinases in human nonpigmented ciliary epithelial cells,” Journal of Pharmacology and Experimental Therapeutics, vol. 316, no. 3, pp. 1219–1228, 2006. View at Publisher · View at Google Scholar · View at Scopus
  128. A. Crooke, B. Colligris, and J. Pintor, “Update in glaucoma medicinal chemistry: emerging evidence for the importance of melatonin analogues,” Current Medicinal Chemistry, vol. 19, no. 21, pp. 3508–3522, 2012. View at Google Scholar
  129. J. Pintor, T. Peláez, C. H. V. Hoyle, and A. Peral, “Ocular hypotensive effects of melatonin receptor agonists in the rabbit: further evidence for an MT3 receptor,” British Journal of Pharmacology, vol. 138, no. 5, pp. 831–836, 2003. View at Publisher · View at Google Scholar · View at Scopus
  130. S. Alcantara-Contreras, K. Baba, and G. Tosini, “Removal of melatonin receptor type 1 increases intraocular pressure and retinal ganglion cells death in the mouse,” Neuroscience Letters, vol. 494, no. 1, pp. 61–64, 2011. View at Publisher · View at Google Scholar · View at Scopus
  131. M. A. Babizhayev and A. Bunin Ya., “Lipid peroxidation in open-angle glaucoma,” Acta Ophthalmologica, vol. 67, no. 4, pp. 371–377, 1989. View at Google Scholar · View at Scopus
  132. M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, and K. Kangawa, “Ghrelin is a growth-hormone-releasing acylated peptide from stomach,” Nature, vol. 402, no. 6762, pp. 656–660, 1999. View at Publisher · View at Google Scholar · View at Scopus
  133. H. Hosoda, M. Kojima, H. Matsuo, and K. Kangawa, “Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue,” Biochemical and Biophysical Research Communications, vol. 279, no. 3, pp. 909–913, 2000. View at Publisher · View at Google Scholar · View at Scopus
  134. A. Rocha-Sousa, J. Saraiva, T. Henriques-Coelho, F. Falcão-Reis, J. Correia-Pinto, and A. F. Leite-Moreira, “Ghrelin as a novel locally produced relaxing peptide of the iris sphincter and dilator muscles,” Experimental Eye Research, vol. 83, no. 5, pp. 1179–1187, 2006. View at Publisher · View at Google Scholar · View at Scopus
  135. A. Rocha-Sousa, P. Alves-Faria, I. Falcão-Pires, F. Falcão-Reis, and A. F. Leite-Moreira, “Analyses of aqueous humour ghrelin levels of eyes with and without glaucoma,” British Journal of Ophthalmology, vol. 93, no. 1, pp. 131–132, 2009. View at Publisher · View at Google Scholar · View at Scopus
  136. A. Katsanos, A. Dastiridou, P. Georgoulias, P. Cholevas, M. Kotoula, and E. E. Tsironi, “Plasma and aqueous humour levels of ghrelin in open-angle glaucoma patients,” Clinical and Experimental Ophthalmology, vol. 39, no. 4, pp. 324–329, 2011. View at Publisher · View at Google Scholar · View at Scopus
  137. A. Rocha-Sousa, M. Tavares-Silva, P. Pereira-Silva et al., “Ghrelin is expressed in the ciliary body and presents a significant and sustained hypotensive effect in acute glaucoma models,” ARVO Meeting Abstracts, vol. 53, 2012. View at Google Scholar
  138. A. H. Danser, F. H. Derkx, P. J. Admiraal, J. Deinum, P. T. de Jong, and M. A. Schalekamp, “Angiotensin levels in the eye,” Investigative Ophthalmology & Visual Science, vol. 35, no. 3, pp. 1008–1018, 1994. View at Google Scholar
  139. A. Vaajanen and H. Vapaatalo, “Local ocular renin-angiotensin system—a target for glaucoma therapy?” Basic and Clinical Pharmacology and Toxicology, vol. 109, no. 4, pp. 217–224, 2011. View at Publisher · View at Google Scholar · View at Scopus
  140. M. Ramirez, E. A. Davidson, L. Luttenauer et al., “The renin-angiotensin system in the rabbit eye,” Journal of Ocular Pharmacology and Therapeutics, vol. 12, no. 3, pp. 299–312, 1996. View at Google Scholar
  141. R.-F. Wang, S. M. Podos, T. W. Mittag, and T. Yokoyoma, “Effect of CS-088, an angiotensin AT1 receptor antagonist, on intraocular pressure in glaucomatous monkey eyes,” Experimental Eye Research, vol. 80, no. 5, pp. 629–632, 2005. View at Publisher · View at Google Scholar · View at Scopus
  142. C. Tikellis, S. Bernardi, and W. C. Burns, “Angiotensin-converting enzyme 2 is a key modulator of the renin-angiotensin system in cardiovascular and renal disease,” Current Opinion in Nephrology and Hypertension, vol. 20, no. 1, pp. 62–68, 2011. View at Publisher · View at Google Scholar · View at Scopus
  143. A. Vaajanen, H. Vapaatalo, H. Kautiainen, and O. Oksala, “Angiotensin (1–7) reduces intraocular pressure in the normotensive rabbit eye,” Investigative Ophthalmology & Visual Science, vol. 49, no. 6, pp. 2557–2562, 2008. View at Publisher · View at Google Scholar · View at Scopus
  144. H. A. Reitsamer and J. W. Kiel, “Relationship between ciliary blood flow and aqueous production in rabbits,” Investigative Ophthalmology & Visual Science, vol. 44, no. 9, pp. 3967–3971, 2003. View at Publisher · View at Google Scholar · View at Scopus
  145. C. Costagliola, F. Parmeggiani, F. Semeraro, and A. Sebastiani, “Selective serotonin reuptake inhibitors: a review of its effects on intraocular pressure,” Current Neuropharmacology, vol. 6, no. 4, pp. 293–310, 2008. View at Publisher · View at Google Scholar · View at Scopus
  146. B. T. Gabelt, M. Okka, T. R. Dean, and P. L. Kaufman, “Aqueous humor dynamics in monkeys after topical R-DOI,” Investigative Ophthalmology & Visual Science, vol. 46, no. 12, pp. 4691–4696, 2005. View at Publisher · View at Google Scholar · View at Scopus
  147. N. A. Sharif, M. A. McLaughlin, and C. R. Kelly, “AL-34662: a potent, selective, and efficacious ocular hypotensive serotonin-2 receptor agonist,” Journal of Ocular Pharmacology and Therapeutics, vol. 23, no. 1, pp. 1–13, 2007. View at Publisher · View at Google Scholar · View at Scopus
  148. T. J. Bunch, J. L. Seeman, B. T. Gabelt et al., “BVT.28949 as a potential ocular hypotensive agent in monkeys,” Investigative Ophthalmology & Visual Science, vol. 45, 2004, ARVO E-Abstract 5040. View at Google Scholar
  149. V. D. Wagh, P. N. Patil, S. J. Surana, and K. V. Wagh, “Forskolin: upcoming antiglaucoma molecule,” Journal of Postgraduate Medicine, vol. 58, no. 3, pp. 199–202, 2012. View at Google Scholar
  150. H. Metzger and E. Lindner, “The positive inotropic-acting forskolin, a potent adenylatecyclase activator,” Arzneimittel-Forschung, vol. 31, no. 8, pp. 1248–1250, 1981. View at Google Scholar · View at Scopus
  151. N. Pescosolido and A. Librando, “Oral administration of an association of forskolin, rutin and vitamins B1 and B2 potentiates the hypotonising effects of pharmacological treatments in POAG patients,” La Clinica terapeutica, vol. 161, no. 3, pp. e81–e85, 2010. View at Google Scholar · View at Scopus